"Top Regulator of AIDS Drugs Quits Her Post"

Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

"Top Regulator of AIDS Drugs Quits Her Post"

Wall Street Journal (12/24/90)
Chase, Marilyn

Abstract: Dr. Ellen Cooper, director of the Food and Drug Administration's antiviral drug division for the past three years, has resigned her post and asked for transfer because of battle fatigue and burnout. Cooper has been the nation's top AIDS drug regulator and a major target of AIDS activists, some of whom, including Project Inform's Martin Delaney, recently fiercely criticized her for the delay in approval of experimental drugs ddI and ddC. She has also been criticized for not liberalizing criteria for approving drugs to allow the use of critical markers such as T4-cell levels and other surrogates. Other activists, however, said her departure would only further delay approval of ddI and ddC. Cooper said that support from the Health and Human Services Department had eroded, with officials often leaking news to AIDS activists and "feeding the frenzy," exacerbating her stress and burnout. Related Story: WP (12/24) P. A13

901224
AD901533

Copyright © 1990 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.